Skip to main content
Premium Trial:

Request an Annual Quote

GenDx Gets Health Canada Approval for HLA Genotyping Test

NEW YORK — Dutch molecular diagnostics firm Genome Diagnostics (GenDx) said on Friday that it has received approval from Canadian regulators for the in vitro diagnostic use of its NGSgo-MX11-3 human leukocyte antigen genotyping test.

NGSgo-MX11-3 provides multiplexed genotyping of 11 HLA loci, using next-generation sequencing and the company's NGSengine software. The genotyping data can be used to help match patients and donors for stem cell transplantation.

Last year, Utrecht-based GenDx received approval from Health Canada for IVD use of two other HLA genotyping tests: NGSgo-AmpX v2 for individual HLA gene amplification and NGSgo-MX6-1 for multiplexed amplification of six HLA genes.

"This latest addition of MX11-3 fits into the trend of applying multiplexed amplification and sequencing of 11 HLA genes of every patient and donor in a single run," GenDx CEO Wietse Mulder said in a statement.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.